From: Vaccine equity in low and middle income countries: a systematic review and meta-analysis
Immunisations Included | N (%) | Studies |
---|---|---|
1974 EPI Vaccines (At least one each dose of DTP, MCV, BCG, & OPV/IPV) | 41 (37.96%) | [3, 7, 19, 21, 22, 24, 28, 34, 35, 42, 50, 51, 54, 58, 59, 62, 64, 65, 68, 69, 71, 77, 80, 82, 86–88, 93, 98–101, 104, 105, 108–111, 113, 115, 116] |
1974 EPI Vaccines & HBV | 10 (9.26%) | |
1974 EPI vaccines, HBV, & MMR | 2 (1.85%) | |
1974 EPI vaccines, HBV, & JE | 2 (1.85%) | |
1974 EPI Vaccines, HBV, & Hib | 7 (6.48%) | |
1974 EPI Vaccines, HBV, Hib, & YF | 2 (1.85%) | |
1974 EPI Vaccines, HBV, Hib, & MMR | 2 (1.85%) | |
DTP, MCV, & BCG | 4 (3.70%) | |
DTP & MCV | 4 (3.70%) | |
DTP | 4 (3.70%) | |
MCV | 11 (10.12%) | |
Polio (OPV/IPV) | 3 (2.78%) | |
HBV | 3 (2.78%) | |
Influenza | 2 (1.85%) | |
Other | 7 (6.48%) | |
Not given | 4 (3.70%) |